European Archives - Page 61 of 1344 - European Medical Journal

Fixed Airway Obstruction Found in 33% of Severe Asthma Cases

Fixed Airway Obstruction Found in 33% of Severe Asthma Cases

Fixed airway obstruction in severe asthma shows distinct clinical and biological traits, with some patients improving over time.

Health Risks After Traumatic Spinal Cord Injury

Chronic Disease Risks After Traumatic Spinal Cord Injury

Study finds traumatic spinal cord injury linked to higher long-term risks of chronic illness, including heart disease and diabetes.

skin cancer

Risk-Based Screening Improves Skin Cancer Detection After Transplant

A targeted screening programme improved early skin cancer detection in transplant recipients without increasing healthcare demands.

Neonatal Mortality Risk Up to 81% Higher in Black Mothers

Neonatal Mortality Risk Up to 81% Higher in Black Mothers

Study finds persistent socioeconomic and ethnic inequalities in neonatal mortality across England and Wales between 2012 and 2022.

Nasal Saline Irrigation Enhances Allergic Rhinitis Treatment

Nasal Saline Irrigation Enhances Allergic Rhinitis Treatment

A multicentre, randomised, controlled trial evaluated the efficacy and safety of integrating nasal saline irrigation with Aze-Flu nasal spray.

Mediterranean Diet Benefits MASLD and Sustainability

Recent research has examined the dual benefits of dietary patterns that improve MASLD outcomes while reducing environmental impact.

Cladribine Effective in Treatment-Naive Relapsing-Remitting MS

Study reveals cladribine reduces disability progression in Treatment-Naive Relapsing-Remitting MS more so than sphingosine-1-phosphate receptor modulators.

New Evidence Supports CAR-T Cells as a Potential Breakthrough in SLE Care

A new systematic review shows CAR T-cell therapy delivers high remission rates, reduced disease activity, and low toxicity in refractory lupus, signalling major treatment potential.

Chagas Disease Burden Rising in Migrant Populations

Global Chagas disease cases decline, yet prevalence grows in non-endemic countries due to migration, new study shows.

Chronic Spontaneous Urticaria Treatment Breakthrough

Recent research has highlighted the potential of barzolvolimab, a first-in-class monoclonal antibody developed to inhibit the KIT receptor.